| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-08-30 21:40:37 UTC |
|---|
| Update Date | 2021-09-26 22:48:57 UTC |
|---|
| HMDB ID | HMDB0242425 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol |
|---|
| Description | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol belongs to the class of organic compounds known as ibogan-type alkaloids. These are indole alkaloids with a structure based on the ibogamine skeleton or a derivative thereof. Ibogamine is a pentacyclic heterocyclic compound consisting of an indole fused to an azepane-containing tricyclic moiety ring. Iboga alkaloids arise from the cyclization of a secodine-type precursor through the formation of a 16,21 bond. Based on a literature review very few articles have been published on (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol. This compound has been identified in human blood as reported by (PMID: 31557052 ). (1s,17r)-17-ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CCC1CC2CC3C1N(C2)CCC1=C3NC2=CC=C(O)C=C12 InChI=1S/C19H24N2O/c1-2-12-7-11-8-16-18-14(5-6-21(10-11)19(12)16)15-9-13(22)3-4-17(15)20-18/h3-4,9,11-12,16,19-20,22H,2,5-8,10H2,1H3 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C19H24N2O |
|---|
| Average Molecular Weight | 296.414 |
|---|
| Monoisotopic Molecular Weight | 296.188863401 |
|---|
| IUPAC Name | 17-ethyl-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-7-ol |
|---|
| Traditional Name | 17-ethyl-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-7-ol |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCC1CC2CC3C1N(C2)CCC1=C3NC2=CC=C(O)C=C12 |
|---|
| InChI Identifier | InChI=1S/C19H24N2O/c1-2-12-7-11-8-16-18-14(5-6-21(10-11)19(12)16)15-9-13(22)3-4-17(15)20-18/h3-4,9,11-12,16,19-20,22H,2,5-8,10H2,1H3 |
|---|
| InChI Key | RAUCDOKTMDOIPF-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as ibogan-type alkaloids. These are indole alkaloids with a structure based on the ibogamine skeleton or a derivative thereof. Ibogamine is a pentacyclic heterocyclic compound consisting of an indole fused to an azepane-containing tricyclic moiety ring. Iboga alkaloids arise from the cyclization of a secodine-type precursor through the formation of a 16,21 bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Ibogan-type alkaloids |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Ibogan-type alkaloids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Ibogan skeleton
- Catharanthine skeleton
- Hydroxyindole
- Pyrroloazepine
- 3-alkylindole
- Indole
- Indole or derivatives
- Azepine
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Piperidine
- Benzenoid
- Heteroaromatic compound
- Pyrrole
- Tertiary amine
- Tertiary aliphatic amine
- Organoheterocyclic compound
- Azacycle
- Organooxygen compound
- Organonitrogen compound
- Amine
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 4.46 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.4469 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.63 minutes | 32390414 |
Predicted Kovats Retention IndicesDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1[NH]4 | 2882.1 | Semi standard non polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1[NH]4 | 2917.4 | Standard non polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1[NH]4 | 3599.7 | Standard polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #2 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C | 2925.6 | Semi standard non polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #2 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C | 2846.3 | Standard non polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TMS,isomer #2 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C | 3532.4 | Standard polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1N4[Si](C)(C)C | 2886.8 | Semi standard non polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1N4[Si](C)(C)C | 2815.4 | Standard non polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C)=CC=C1N4[Si](C)(C)C | 3347.2 | Standard polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1[NH]4 | 3110.7 | Semi standard non polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1[NH]4 | 3185.4 | Standard non polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1[NH]4 | 3715.2 | Standard polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #2 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C(C)(C)C | 3101.3 | Semi standard non polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #2 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C(C)(C)C | 3117.8 | Standard non polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,1TBDMS,isomer #2 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4[Si](C)(C)C(C)(C)C | 3621.6 | Standard polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TBDMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1N4[Si](C)(C)C(C)(C)C | 3261.7 | Semi standard non polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TBDMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1N4[Si](C)(C)C(C)(C)C | 3318.5 | Standard non polar | 33892256 | | (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol,2TBDMS,isomer #1 | CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1N4[Si](C)(C)C(C)(C)C | 3487.7 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol GC-MS (Non-derivatized) - 70eV, Positive | splash10-014i-1290000000-f4b5acd785b6c643f768 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 10V, Positive-QTOF | splash10-0002-0090000000-7a52ccd6b13581152274 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 20V, Positive-QTOF | splash10-0002-0090000000-7a52ccd6b13581152274 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 40V, Positive-QTOF | splash10-0400-0980000000-7591e714ad6a83186bf4 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 10V, Negative-QTOF | splash10-0002-0090000000-6097eef1edfc41faed9b | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 20V, Negative-QTOF | splash10-0002-0090000000-6097eef1edfc41faed9b | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (1S,17R)-17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol 40V, Negative-QTOF | splash10-00kf-0190000000-4198e3f8928f0e0784e6 | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|